Who funds this research project?

This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.

What is the EU contribution?

The European Commission contributes €22.6M toward a total project budget of €22.6M.

Which EU programme funds it?

The project is funded under Horizon Europe (2021–2027), call HORIZON-HLTH-2021-DISEASE-04.

Who coordinates the project?

The project is coordinated by EATRIS ERIC (NL).

What is the project timeline?

The project runs from 2022-09-01 to 2027-08-31 — approximately 5 years.

Where can I find the full project record?

The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101057442.

CORDIS · 101057442 · HORIZON

REMEDi4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL

Coordinator: EATRIS ERIC (NL)

REMEDi4ALL aims to establish Europe's leadership globally in the repurposing of medicines by creating a vibrant community of practice covering all relevant sectors and disciplines. REMEDi4ALL will establish and operate a permanent European research and innovation platform comprising the complete value chain for cutting edge, patient-focused repurposing, collaborating with users to execute high potential projects at any phase of development, upskilling all stakeholder groups through a comprehensive education and training portfolio, and advancing cross-sectoral policy dialogue with all relevant…

EU contribution

€22.6M

Total cost

€22.6M

Period

2022-09-01 → 2027-08-31

Framework

Horizon Europe (2021–2027)

Funding scheme

HORIZON-RIA

Call

HORIZON-HLTH-2021-DISEASE-04

Status

SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €22.6M awarded to the consortium. The project runs over approximately 5 years from 2022-09-01 to 2027-08-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

More from NL

see all →

Other HORIZON projects

see all →

Frequently asked questions

Who funds this research project?: This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
What is the EU contribution?: The European Commission contributes €22.6M toward a total project budget of €22.6M.
Which EU programme funds it?: The project is funded under Horizon Europe (2021–2027), call HORIZON-HLTH-2021-DISEASE-04.
Who coordinates the project?: The project is coordinated by EATRIS ERIC (NL).
What is the project timeline?: The project runs from 2022-09-01 to 2027-08-31 — approximately 5 years.
Where can I find the full project record?: The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101057442.

Source: CORDIS · 101057442